Options Research

Compare current setups

Put up to five tickers on the same scale. The comparison separates directional pressure, participation, volatility, trend agreement and data quality.

Return to Options Radar

Maximum five tickers. Scores measure evidence alignment, not the probability of a gain.

Strongest evidence alignment SABS 53/100

The highest composite alignment across pressure, participation, trend fit and volatility.

Widest priced move SABS 8.8%

The largest near-term move currently implied by the retained chain.

Strongest participation SABS 0/100

The most active setup relative to open interest and contract-level flow.

Cleanest evidence SABS A · 97/100

The comparison member with the strongest underlying, chain, quote and volatility coverage.

Side-by-side evidence

One scale, comparable inputs

1 current setups
Ticker Read Conviction Pressure Participation Volatility Trend fit Expected move Put-call Volume/OI Evidence
SABSSAB Biotherapeutics Inc Bearish 53 -91 0 61 33 8.8% - 0.00 A97/100
Bearish

SABS

SAB Biotherapeutics Inc

53
Priced range 3.26–3.88
Pressure
-91
Participation
0
Trend fit
33
Reference IV
0.36

Options imply 3.26 to 3.88. Max pain at 3.00 lies outside the priced range, so it is a weak near-term anchor.

Open SABS research